For use outside the EU, the regulator backed a single-dose oral approach that treats all stages and could spare patients ...

Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of ...

Although African trypanosomiasis, also known as sleeping sickness, has fallen in prominence to become extremely rare, the drug acoziborole may help the World Health Organization’s goal of eradicating ...

Press Release - • Recommendation based on Phase II/III study demonstrating up to 96 per cent success rates at 18 months across both early and advanced stages of T.b. gambiense, the most common form of ...

Togo has received validation from the World Health Organization (WHO) for having eliminated human African trypanosomiasis or “sleeping sickness” as a public health problem, becoming the first country ...

Thanks to efforts by MSF, the immediate future for those with sleeping sickness looks considerably brighter than the recent past, but the long-term prognosis isn't clear. The story of the reemergence ...

In another step to combat deadly African sleeping sickness, the Bill & Melinda Gates Foundation has presented a $22.6 million grant to the University of North Carolina at Chapel Hill to fund a Phase ...

Tsetse fly. It transmits parasites that cause sleeping sickness in humans and Nagana disease in animals. [iStockphoto] Tsetse flies - which transmit tiny parasites that cause sleeping sickness in ...

A single dose of oral acoziborole resulted in a greater than 95% cure or probable cure rate for human African trypanosomiasis (HAT), also known as sleeping sickness, according to results from a ...